Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Gross Profit (2020 - 2025)

Historic Gross Profit for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $95000.0.

  • Silence Therapeutics' Gross Profit rose 10443.72% to $95000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 15877.65%. This contributed to the annual value of $31.4 million for FY2024, which is 6749.04% up from last year.
  • Silence Therapeutics' Gross Profit amounted to $95000.0 in Q3 2025, which was up 10443.72% from $139000.0 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Gross Profit registered a high of $23.3 million during Q4 2024, and its lowest value of -$2.6 million during Q2 2024.
  • Moreover, its 5-year median value for Gross Profit was $1.2 million (2021), whereas its average is $3.3 million.
  • As far as peak fluctuations go, Silence Therapeutics' Gross Profit surged by 34393414.48% in 2021, and later plummeted by 24191.76% in 2024.
  • Over the past 5 years, Silence Therapeutics' Gross Profit (Quarter) stood at $1.8 million in 2021, then crashed by 42.54% to $1.1 million in 2022, then fell by 12.05% to $934587.3 in 2023, then skyrocketed by 2389.55% to $23.3 million in 2024, then crashed by 99.59% to $95000.0 in 2025.
  • Its last three reported values are $95000.0 in Q3 2025, $139000.0 for Q2 2025, and $88000.0 during Q1 2025.